Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Roswell Park's Dr. Gal Shafirstein / Simphotek Project

<< Previous

Bullboard Posts

Next >>

Comment by langostaon Feb 16, 2022 3:20pm

540 Views

Post# 34435028

RE:RE:Roswell Park's Dr. Gal Shafirstein / Simphotek Project

patience69 wrote: Wow Eog great find. This has been a puzzle in my mind for a while. Lumeda has their unique laser system & I bet our drug would have done great. To answer the question I believe IMO that not going with them was a great business decision. It would have been short sighted. Maybe even closed the door on what could be in the oven in way of a partnership. I cant see what we would have gained except for possibly a few months.

Confused here?

Not going with them? I thought it was them not going with us. (Once more, it may be my age).

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland